Advanced Search:
Equity Index

PCIB.OL - PCI BIOTECH HOLD

kr1.56  -0.088 (-5.34%)

Updated: 08:42 May 10, 2024 EST

Next Session's AI Forecast

82.49%

Avg. Accuracy (AI)

kr1.38

Next Week's AI Forecast

83.33%

Trend's Accuracy (AI)

kr1.59

PCI BIOTECH HOLD's Position Within the Biotechnology Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

PCI BIOTECH HOLD - HISTORICAL DATA 6M

  • Last price

    kr1.56

  • Daily change

    kr-0.088

  • Previous Close

    kr1.648

  • Last Updated

    08:42 May 10, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
1.04 -0.36 -0.37 -0.33 0.13

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
1.2 2.55 2.85 3.19 4.59

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
50% 98.18% 40.3% 23.58%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
1.65 0.61% 1.64 -2.96% 1.69 -15.5% 2

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
0.75 -1 1 42.86

PCI BIOTECH HOLD Technical Analysis News

PCI BIOTECH HOLD

UllernchaussEen 64
Oslo 0379
Norway
47 67 11 54 00
https://www.pcibiotech.com

Sectors: Healthcare
Industry: Biotechnology
Description

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.

Corporate Governance

PCI Biotech Holding ASA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.